These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. Improvement of Local Cell Delivery Using Helix Transendocardial Delivery Catheter in a Porcine Heart. Mitsutake Y; Pyun WB; Rouy D; Foo CWP; Stertzer SH; Altman P; Ikeno F Int Heart J; 2017 May; 58(3):435-440. PubMed ID: 28539564 [TBL] [Abstract][Full Text] [Related]
64. Intraperitoneal injection (IP), Intravenous injection (IV) or anal injection (AI)? Best way for mesenchymal stem cells transplantation for colitis. Wang M; Liang C; Hu H; Zhou L; Xu B; Wang X; Han Y; Nie Y; Jia S; Liang J; Wu K Sci Rep; 2016 Aug; 6():30696. PubMed ID: 27488951 [TBL] [Abstract][Full Text] [Related]
65. Stem cell engineering for treatment of heart diseases: potentials and challenges. Li SC; Wang L; Jiang H; Acevedo J; Chang AC; Loudon WG Cell Biol Int; 2009 Mar; 33(3):255-67. PubMed ID: 19084605 [TBL] [Abstract][Full Text] [Related]
68. Repeated Cell Therapy: A Paradigm Shift Whose Time Has Come. Bolli R Circ Res; 2017 Mar; 120(7):1072-1074. PubMed ID: 28179431 [TBL] [Abstract][Full Text] [Related]
69. Mesenchymal stem cell administration at coronary artery reperfusion in the rat by two delivery routes: a quantitative assessment. Hale SL; Dai W; Dow JS; Kloner RA Life Sci; 2008 Sep; 83(13-14):511-5. PubMed ID: 18755200 [TBL] [Abstract][Full Text] [Related]
70. Cell therapy for heart disease: current status and future directions. Kahlon A; Vaidya G; Bolli R Minerva Cardioangiol; 2018 Jun; 66(3):273-291. PubMed ID: 29327894 [TBL] [Abstract][Full Text] [Related]
71. Concise Review: Heart-Derived Cell Therapy 2.0: Paracrine Strategies to Increase Therapeutic Repair of Injured Myocardium. Rafatian G; Davis DR Stem Cells; 2018 Dec; 36(12):1794-1803. PubMed ID: 30171743 [TBL] [Abstract][Full Text] [Related]
72. Direct somatic cell reprogramming: treatment of cardiac diseases. Guo C; Patel K; Qian L Curr Gene Ther; 2013 Apr; 13(2):133-8. PubMed ID: 23320478 [TBL] [Abstract][Full Text] [Related]
73. Exploitation of stem cell homing for gene delivery. Penn MS; Khalil MK Expert Opin Biol Ther; 2008 Jan; 8(1):17-30. PubMed ID: 18081534 [TBL] [Abstract][Full Text] [Related]
74. Cardiac regeneration - Past advancements, current challenges, and future directions. Pezhouman A; Nguyen NB; Kay M; Kanjilal B; Noshadi I; Ardehali R J Mol Cell Cardiol; 2023 Sep; 182():75-85. PubMed ID: 37482238 [TBL] [Abstract][Full Text] [Related]
76. Magnetic resonance imaging (MRI) for the assessment of myocardial viability: an evidence-based analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2010; 10(15):1-45. PubMed ID: 23074392 [TBL] [Abstract][Full Text] [Related]
77. The current state of stem cell therapeutics: Canadian approaches in the international context. Noiseux N; Marquis-Gravel G; Mansour S; Shahzad U; Stewart DJ; Yau TM Can J Cardiol; 2014 Nov; 30(11):1361-9. PubMed ID: 25249498 [TBL] [Abstract][Full Text] [Related]
79. Stem Cell Therapy and Administration Routes After Stroke. Rodríguez-Frutos B; Otero-Ortega L; Gutiérrez-Fernández M; Fuentes B; Ramos-Cejudo J; Díez-Tejedor E Transl Stroke Res; 2016 Oct; 7(5):378-87. PubMed ID: 27384771 [TBL] [Abstract][Full Text] [Related]
80. Intramyocardial delivery of FGF2 in combination with radio frequency transmyocardial revascularization. Bao J; Naimark W; Palasis M; Laham R; Simons M; Post MJ Catheter Cardiovasc Interv; 2001 Jul; 53(3):429-34. PubMed ID: 11458429 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]